Auxly Maintains Top Position in 2.0, Dominates Vape Sales and Grows National Market Share Through 1.0 Expansion in 2021
13 Janeiro 2022 - 9:30AM
Auxly Cannabis Group Inc. (TSX - XLY) (“
Auxly” or
the “
Company”), a leading consumer packaged goods
company in the cannabis products market, is thrilled to report its
continued national leadership in Cannabis 2.0 product sales in
2021, securing a 15% share of the growing category (up from 14% in
2020), as confirmed by Headset Canadian Insights data. The
Company’s #1 spot is driven by its dominance in the vapour segment,
where it achieved 23% national market share for the year, with all
three of its vape brands - Back Forty, Kolab Project and Foray –
securing a spot in the top 5 selling brands across the country.
The Company also saw a steady
quarter-over-quarter growth in total market share, achieving its
strategic objective of reaching the #5 LP position in overall sales
by the end of 2021. As one of the few Canadian LPs to gain market
share throughout the year, Auxly successfully captured 7.4% of the
total market in Q4 2021 (up from 4% in Q1 2021), securing a new
leading position among the top performing LPs in the country.
Leading the growth in market share was the Company’s expansion into
dried flower and pre-rolls, which still account for over 75% of
national cannabis sales, and remains a key growth driver for Auxly
going into the new year where it will leverage the added support of
its newly acquired 1.1 million sq. ft. greenhouse cannabis
cultivation facility in Leamington, ON.
“2021 was a phenomenal year for Auxly. It
validated our focused strategy of bringing innovative and
differentiated products to the Canadian cannabis market under
brands that consumers can trust and love,” said Hugo Alves, CEO of
Auxly. “I want to express my utmost gratitude to everyone at Auxly
for their hard work and determination, especially during another
year of the pandemic. We’ve solidified our position within the
top-ranking LPs in the country and have no intention of slowing
down as we further optimize our operations to facilitate long-term
growth and continue to build deeper connections with our targeted
consumers through our innovative branded cannabis products. We
couldn’t be more excited for 2022.”
Additional Operational Highlights for
2021 Include:
-
Launched 52 SKUs in 2021, including 10 first-to-market
innovations such as Kolab Project 232 Series Live Terpene
Sticks;
-
Made significant progress in building to leadership in both the
dried flower and pre-roll categories with the launch of new and
exciting product formats that include Back Forty 40s and the
introduction of unique cannabis strains that Canadian consumers
trust and love, like one of Ontario’s top selling dried flower
SKUs, Back Forty’s Wedding Pieii;
-
Acquired the remaining equity interest in its joint venture
project, Sunens Farm Inc., a state-of-the-art, 1.1 million sq. ft.
greenhouse cannabis cultivation facility in Leamington, Ontario,
providing the Company with complete control over large-scale
cultivation and access to a proprietary genetic library of more
than 150 cannabis strains to supply its growing product suite;
-
Strengthened its Board of Directors with the appointment of Murray
McGowan, strategic partner Imperial Brands’ Chief Strategy and
Development Officer; and
-
Graduated to the Toronto Stock Exchange, raising the Company’s
profile in the investment community as it strives to build
long-term shareholder value.
As the Company looks ahead to 2022, Auxly
continues to be driven by its unwavering commitment to Canadian
consumers, helping them live happier lives through its curated
portfolio of branded cannabis products that deliver on the
Company’s promise of quality, safety and efficacy.
ON BEHALF OF THE BOARD
"Hugo Alves” CEO
About Auxly Cannabis Group Inc. (TSX:
XLY) (OTCQX: CBWTF)
Auxly is a leading Canadian cannabis company
dedicated to bringing innovative, effective, and high-quality
cannabis products to the wellness and adult-use markets. Auxly's
experienced team of industry first-movers and enterprising
visionaries have secured a diversified supply of raw cannabis,
strong clinical, scientific and operating capabilities and leading
research and development infrastructure in order to create trusted
products and brands in an expanding global market.
Learn more at www.auxly.com and stay up to date
at Twitter: @AuxlyGroup; Instagram:
@auxlygroup; Facebook: @auxlygroup; LinkedIn:
company/auxlygroup/.
Investor Relations:
For investor enquiries please contact our
Investor Relations Team: Email: IR@auxly.comPhone:
1.833.695.2414
Media Enquiries
(only):
For media enquiries or to set up an interview
please contact:Email: press@auxly.com
Notice Regarding Forward Looking
Information:
This news release contains certain
"forward-looking information" within the meaning of applicable
Canadian securities law. Forward-looking information is frequently
characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed" and other similar words, or
information that certain events or conditions "may" or "will"
occur. This information is only a prediction. Various assumptions
were used in drawing the conclusions or making the projections
contained in the forward-looking information throughout this news
release. Forward looking information includes, but is not limited
to: the Company’s execution of its product development,
commercialization strategy and expansion plans; the relevance of
the Company’s current and proposed products; consumer preferences;
political change, future legislative and regulatory developments
involving cannabis and cannabis products; and competition and other
risks affecting the Company in particular and the cannabis industry
generally.
A number of factors could cause actual results
to differ materially from a conclusion, forecast or projection
contained in the forward-looking information in this release
including, but not limited to, whether: the Company is able to
maintain and grow its market share; the Company’s subsidiaries and
partners are able to maintain the necessary regulatory
authorizations to conduct business; there is acceptance and demand
for current and future Company products by consumers and provincial
purchasers; and general economic, financial market, regulatory and
political conditions in which the Company operates will remain the
same. Additional risk factors are disclosed in the annual
information form of the Company for the financial year ended
December 31, 2020 dated April 23, 2021.
The forward-looking information in this release
is based on information currently available and what management
believes are reasonable assumptions. Forward-looking information
speaks only to such assumptions as of the date of this release. In
addition, this release may contain forward-looking information
attributed to third party industry sources, the accuracy of which
has not been verified by Auxly. Readers should not place undue
reliance on forward-looking information contained in this release.
The forward-looking information contained in this release is
expressly qualified by the foregoing cautionary statements and is
made as of the date of this release. Except as may be required by
applicable securities laws, the Company does not undertake any
obligation to publicly update or revise any forward-looking
information to reflect events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events,
whether as a result of new information, future events or results,
or otherwise.
Neither Toronto Stock Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the Toronto Stock Exchange) accepts responsibility for
the adequacy or accuracy of this release.
i Headset Canadian Insights, Total Canadian Cannabis 2.0 sales,
Jan 1, 2021 – December 31, 2021 ii OCS Data, Wedding Pie 28g SKU
was a top selling SKU in Ontario in Q4 2021
Auxly Cannabis (TSX:XLY)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Auxly Cannabis (TSX:XLY)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024